Nuvalent
Manoj Samant, PhD, is an accomplished professional in the field of clinical development with extensive experience in various leadership roles. Currently serving as the Senior Director of Clinical Science at Nuvalent, Inc. since February 2024, Manoj has previously held positions including Senior Medical Director at Ribon Therapeutics and Director of Clinical Science at Kiniksa Pharmaceuticals. A Senior Principal Scientist at Aileron Therapeutics, Manoj's early career included roles as an Investigator at Amylin Pharmaceuticals and as a Senior Research Associate at the Salk Institute for Biological Studies. Manoj's academic credentials include a Ph.D. in Organic Chemistry from the Indian Institute of Chemical Technology, a Master's Degree in Organic Chemistry from Goa University, and a degree in Clinical Research from Boston College.
This person is not in the org chart
This person is not in any teams
Nuvalent
1 followers
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.